FLGT - Fulgent Genetics Non-GAAP EPS of $3.48 beats by $0.81 revenue of $251.7M beats by $60.6M

Fulgent Genetics press release (NASDAQ:FLGT): Q4 Non-GAAP EPS of $3.48 beats by $0.81. Revenue of $251.7M beats by $60.6M. Shares -5%. Outlook Q1 2022:T otal Revenue of approximately $245 million; Core Revenue including COVID-19 NGS of approximately $32 million, representing growth of 92% year-over-year; Core Revenue excluding COVID-19 NGS of approximately $22 million FY Outlook: Total Revenue of approximately $600 million; Core Revenue excluding COVID-19 NGS of approximately $120 million; GAAP income of approximately $6.00 per share; Non-GAAP income of approximately $7.00 per shareT

For further details see:

Fulgent Genetics Non-GAAP EPS of $3.48 beats by $0.81, revenue of $251.7M beats by $60.6M